Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q2 2023 Earnings Call Transcript August 10, 2023
Trevi Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.09.
Operator: Good afternoon and welcome to the Trevi Therapeutics’ Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. Various remarks that management makes during this conference call about the company’s future expectations, plans and...
